Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus

Koen K.A. Van Rompay, Kimberli A. Schmidt, Jonathan R. Lawson, Raman Singh, Norbert Bischofberger, Marta Marthas

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Simian immunodeficiency virus (SIV) infection of infant macaques is a useful animal model to determine whether topical (oral) administration of antiviral compounds to the nursing infant could reduce human immunodeficiency virus transmission through breast-feeding. The reverse-transcriptase inhibitor tenofovir was selected because of previous demonstrations that systemic drug levels are effective in preventing SIV infection. To mimic the multiple exposures to virus during breast-feeding, 14 infant macaques were fed 15 low doses of SIVmac251 without chemical restraint. Six animals were treated with placebo, and 2 groups of 4 animals received oral topical doses of tenofovir disoproxil fumarate (DF; equivalent to 0.037 mg of tenofovir/day). About half the animals of each group became infected. In a subsequent study, 2 oral inoculations of 4 juvenile macaques with a mixture of tenofovir DF and SIVmac251 induced persistent infection. Topical administration of low doses of tenofovir DF did not protect against oral SIV infection.

Original languageEnglish (US)
Pages (from-to)1508-1513
Number of pages6
JournalJournal of Infectious Diseases
Volume186
Issue number10
DOIs
StatePublished - Nov 15 2002

Fingerprint

Tenofovir
Topical Administration
Simian Immunodeficiency Virus
Macaca
Virus Diseases
Breast Feeding
Reverse Transcriptase Inhibitors
Antiviral Agents
Oral Administration
Nursing
Animal Models
Placebos
HIV
Viruses

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus. / Van Rompay, Koen K.A.; Schmidt, Kimberli A.; Lawson, Jonathan R.; Singh, Raman; Bischofberger, Norbert; Marthas, Marta.

In: Journal of Infectious Diseases, Vol. 186, No. 10, 15.11.2002, p. 1508-1513.

Research output: Contribution to journalArticle

Van Rompay, Koen K.A. ; Schmidt, Kimberli A. ; Lawson, Jonathan R. ; Singh, Raman ; Bischofberger, Norbert ; Marthas, Marta. / Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus. In: Journal of Infectious Diseases. 2002 ; Vol. 186, No. 10. pp. 1508-1513.
@article{66ce1a95ba7a4ff695cb933d4e884a15,
title = "Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus",
abstract = "Simian immunodeficiency virus (SIV) infection of infant macaques is a useful animal model to determine whether topical (oral) administration of antiviral compounds to the nursing infant could reduce human immunodeficiency virus transmission through breast-feeding. The reverse-transcriptase inhibitor tenofovir was selected because of previous demonstrations that systemic drug levels are effective in preventing SIV infection. To mimic the multiple exposures to virus during breast-feeding, 14 infant macaques were fed 15 low doses of SIVmac251 without chemical restraint. Six animals were treated with placebo, and 2 groups of 4 animals received oral topical doses of tenofovir disoproxil fumarate (DF; equivalent to 0.037 mg of tenofovir/day). About half the animals of each group became infected. In a subsequent study, 2 oral inoculations of 4 juvenile macaques with a mixture of tenofovir DF and SIVmac251 induced persistent infection. Topical administration of low doses of tenofovir DF did not protect against oral SIV infection.",
author = "{Van Rompay}, {Koen K.A.} and Schmidt, {Kimberli A.} and Lawson, {Jonathan R.} and Raman Singh and Norbert Bischofberger and Marta Marthas",
year = "2002",
month = "11",
day = "15",
doi = "10.1086/344360",
language = "English (US)",
volume = "186",
pages = "1508--1513",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus

AU - Van Rompay, Koen K.A.

AU - Schmidt, Kimberli A.

AU - Lawson, Jonathan R.

AU - Singh, Raman

AU - Bischofberger, Norbert

AU - Marthas, Marta

PY - 2002/11/15

Y1 - 2002/11/15

N2 - Simian immunodeficiency virus (SIV) infection of infant macaques is a useful animal model to determine whether topical (oral) administration of antiviral compounds to the nursing infant could reduce human immunodeficiency virus transmission through breast-feeding. The reverse-transcriptase inhibitor tenofovir was selected because of previous demonstrations that systemic drug levels are effective in preventing SIV infection. To mimic the multiple exposures to virus during breast-feeding, 14 infant macaques were fed 15 low doses of SIVmac251 without chemical restraint. Six animals were treated with placebo, and 2 groups of 4 animals received oral topical doses of tenofovir disoproxil fumarate (DF; equivalent to 0.037 mg of tenofovir/day). About half the animals of each group became infected. In a subsequent study, 2 oral inoculations of 4 juvenile macaques with a mixture of tenofovir DF and SIVmac251 induced persistent infection. Topical administration of low doses of tenofovir DF did not protect against oral SIV infection.

AB - Simian immunodeficiency virus (SIV) infection of infant macaques is a useful animal model to determine whether topical (oral) administration of antiviral compounds to the nursing infant could reduce human immunodeficiency virus transmission through breast-feeding. The reverse-transcriptase inhibitor tenofovir was selected because of previous demonstrations that systemic drug levels are effective in preventing SIV infection. To mimic the multiple exposures to virus during breast-feeding, 14 infant macaques were fed 15 low doses of SIVmac251 without chemical restraint. Six animals were treated with placebo, and 2 groups of 4 animals received oral topical doses of tenofovir disoproxil fumarate (DF; equivalent to 0.037 mg of tenofovir/day). About half the animals of each group became infected. In a subsequent study, 2 oral inoculations of 4 juvenile macaques with a mixture of tenofovir DF and SIVmac251 induced persistent infection. Topical administration of low doses of tenofovir DF did not protect against oral SIV infection.

UR - http://www.scopus.com/inward/record.url?scp=0037111084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037111084&partnerID=8YFLogxK

U2 - 10.1086/344360

DO - 10.1086/344360

M3 - Article

C2 - 12404171

AN - SCOPUS:0037111084

VL - 186

SP - 1508

EP - 1513

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 10

ER -